Xilio Therapeutics (XLO) Short Interest Ratio & Short Volume → America’s worst nightmare? (From Porter & Company) (Ad) Free XLO Stock Alerts $1.12 -0.06 (-5.08%) (As of 05/13/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Xilio Therapeutics Short Interest DataCurrent Short Volume456,500 sharesPrevious Short Volume379,500 sharesChange Vs. Previous Month+20.29%Dollar Volume Sold Short$474,760.00Short Interest Ratio / Days to Cover0.4Last Record DateApril 30, 2024Outstanding Shares36,910,000 sharesFloat Size8,720,000 sharesShort Percent of Float5.24%Today's Trading Volume273,595 sharesAverage Trading Volume928,099 sharesToday's Volume Vs. Average29% Short Selling Xilio Therapeutics ? Sign up to receive the latest short interest report for Xilio Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatXLO Short Interest Over TimeXLO Days to Cover Over TimeXLO Percentage of Float Shorted Over Time Ad Porter & CompanyAmerica’s worst nightmare?What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late.Click here to watch this bombshell exposé now. Xilio Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024456,500 shares $474,760.00 +20.3%5.2%0.4 $1.04 4/15/2024379,500 shares $478,170.00 +600.2%4.4%0.3 $1.26 3/31/202454,200 shares $58,536.00 -5.9%0.7%0 $1.08 3/15/202457,600 shares $39,456.00 +171.7%0.4%0.3 $0.69 2/29/202421,200 shares $15,030.80 -37.3%0.2%0.1 $0.71 2/15/202433,800 shares $19,854.12 +2,012.5%0.2%0.2 $0.59 Get the Latest News and Ratings for XLO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Xilio Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,600 shares $1,040.00 -75.4%0.0%0 $0.65 1/15/20246,500 shares $4,831.45 +364.3%0.1%0 $0.74 12/31/20231,400 shares $770.00 -92.5%0.0%0 $0.55 12/15/202318,600 shares $13,206.00 -65.6%0.1%0.4 $0.71 11/30/202354,100 shares $51,395.00 +86.6%0.4%2.2 $0.95 11/15/202329,000 shares $38,860.00 +14.6%0.2%1.5 $1.34 10/31/202325,300 shares $54,395.00 -4.5%0.2%1.7 $2.15 10/15/202326,500 shares $46,375.00 +7.7%0.2%2.2 $1.75 9/30/202324,600 shares $51,906.00 +98.4%0.2%2.1 $2.11 9/15/202312,400 shares $29,264.00 -77.0%0.1%1.1 $2.36 8/31/202353,900 shares $154,693.00 -2.7%0.4%4 $2.87 8/15/202355,400 shares $151,242.00 -7.1%0.4%4.2 $2.73 7/31/202359,600 shares $170,456.00 -23.6%0.4%4.1 $2.86 7/15/202378,000 shares $206,700.00 -4.5%0.6%4.9 $2.65 6/30/202381,700 shares $214,054.00 -46.2%0.6%3.6 $2.62 6/15/2023151,800 shares $414,414.00 -21.4%1.2%6.5 $2.73 5/31/2023193,100 shares $588,955.00 -3.3%1.5%8.9 $3.05 5/15/2023199,600 shares $612,772.00 +1.0%1.7%7.6 $3.07 4/30/2023197,600 shares $652,080.00 -12.1%1.8%7 $3.30 4/15/2023224,700 shares $741,510.00 +25.7%2.0%4.3 $3.30 3/31/2023178,700 shares $566,479.00 +58.6%1.6%3.4 $3.17 3/15/2023112,700 shares $311,052.00 +160.9%1.0%2.2 $2.76 2/28/202343,200 shares $155,952.00 +77.1%0.4%0.9 $3.61 2/15/202324,400 shares $77,592.00 -62.6%0.3%0.5 $3.18 1/31/202365,200 shares $237,980.00 +239.6%0.7%1.3 $3.65 1/15/202319,200 shares $51,072.00 -31.4%0.2%0.5 $2.66 12/30/202228,000 shares $75,320.00 +1.8%0.3%1 $2.69 12/15/202227,500 shares $62,700.00 -0.7%0.3%0.9 $2.28 11/30/202227,700 shares $67,034.00 +12.2%0.3%0.3 $2.42 11/15/202224,700 shares $59,280.00 +34.2%0.3%0.3 $2.40 10/31/202218,400 shares $43,056.00 -41.4%0.2%0.2 $2.34 10/15/202231,400 shares $72,220.00 -34.0%0.3%0.3 $2.30 9/30/202247,600 shares $138,516.00 -15.3%0.5%0.4 $2.91 9/15/202256,200 shares $177,030.00 +72.4%0.6%0.4 $3.15America’s worst nightmare? (Ad)What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late.Click here to watch this bombshell exposé now. XLO Short Interest - Frequently Asked Questions What is Xilio Therapeutics' current short interest? Short interest is the volume of Xilio Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 456,500 shares of XLO short. 5.24% of Xilio Therapeutics' shares are currently sold short. Learn More on Xilio Therapeutics' current short interest. What is a good short interest percentage for Xilio Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.24% of Xilio Therapeutics' floating shares are currently sold short. Is Xilio Therapeutics' short interest increasing or decreasing? Xilio Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 456,500 shares, an increase of 20.3% from the previous total of 379,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Xilio Therapeutics' float size? Xilio Therapeutics currently has issued a total of 36,910,000 shares. Some of Xilio Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Xilio Therapeutics currently has a public float of 8,720,000 shares. How does Xilio Therapeutics' short interest compare to its competitors? 5.24% of Xilio Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Xilio Therapeutics: Immuneering Co. (15.37%), Sensei Biotherapeutics, Inc. (0.37%), Rockwell Medical, Inc. (2.13%), HCW Biologics Inc. (0.05%), Lexaria Bioscience Corp. (2.29%), NextCure, Inc. (0.53%), Unicycive Therapeutics, Inc. (2.13%), Ocuphire Pharma, Inc. (4.76%), Cara Therapeutics, Inc. (5.62%), Clene Inc. (0.53%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Xilio Therapeutics stock? Short selling XLO is an investing strategy that aims to generate trading profit from Xilio Therapeutics as its price is falling. XLO shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Xilio Therapeutics? A short squeeze for Xilio Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of XLO, which in turn drives the price of the stock up even further. How often is Xilio Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XLO, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Immuneering Short Squeeze Sensei Biotherapeutics Short Squeeze Rockwell Medical Short Squeeze HCW Biologics Short Squeeze Lexaria Bioscience Short Squeeze NextCure Short Squeeze Unicycive Therapeutics Short Squeeze Ocuphire Pharma Short Squeeze Cara Therapeutics Short Squeeze Clene Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:XLO) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressProtect Your Bank Account Before It’s Too LateWeiss RatingsHow Biden has already won 2024Porter & CompanyUrgent Nvidia WarningAltimetryCharles Payne Demystifies OptionsUnstoppable Prosperity